drugset / Trial / NCT00579371
Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus
NaSingle-groupOpen-labelTreatment
Summary
We hypothesize that the following improvements to islet transplantation will increase the islet mass successfully isolated and allow for engraftment from a single pancreas. The improvements are: * Using Two-Layer method preservation to improve pancreas quality before islet isolation * Maintaining isolated islets in culture before transplantation * Using a steroid-free immunosuppression regimen * Transplanting the best combination of donor and recipient possible after human leukocyte antigens (HLA) screening and final crossmatching
Timeline
- Start
- 2004-03-17
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Islets of Langerhans | Cell therapy | 8000 iu/kg | Other |